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Introduction
The hedgehog (Hh) family of proteins [1] is important in many pat-
terning events in the developing embryo, for instance in determin-
ing digit position [2] and the development of the nervous system
[3]. Hh signal transduction is highly unusual and some of its path-
way components act in a rather unique manner [1]. As shown in
Fig. 1A, the Hh pathway contains two receptors, i.e. the 12-pass
transmembrane receptor Patched 1 (Ptch1) [4] and the 7-pass
transmembrane receptor Smoothened (Smo) [5]. When the path-
way is active, due to binding of Shh to Ptch1 (thereby alleviating
its inhibitory action on Smo), target gene transcription is initiated
through the Gli family of transcription factors [6]. One of these tar-
get genes is Ptch1, creating a negative feedback loop [7], and
increased expression of Ptch1 is thus indicative of pathway activ-
ity. Assaying Ptch1 levels thus enables to analyse tissue responses
to generated Shh.
Recently, it has become clear that the Hh pathway is not only
active in the developing embryo, but also in the adult organism.
Intestinal tract morphostasis is critically dependent on proper Hh
signalling [8] and Hh functions in a range of beneficial processes
to salvage damaged tissue in different ischaemia models [9–13].
In a kidney ischaemia-reperfusion model, up-regulation by Shh
was shown in reperfusion model, and a link with HIF-1 was sug-
gested but not mechanistically established [11]. Conversely, in a
developmental model, a role for HIF-1 in inducing Shh expres-
sion was established by the use of a pharmacological inhibitor,
however the implications of this for adult physiology were not
addressed [14].
Recent work by Kusano et al. has shown the involvement of Hh
in myocardial ischaemia in the adult organism, and the use of Shh
cDNA enabled the authors to reduce apoptosis in the afflicted area,
to recruit progenitor cells, and to enhance tissue vascularization
[10]. The salvage experiments using Shh protein or DNA in the
abovementioned papers look like promising therapeutic options
but although the authors provide an in-depth description of the
involvement of Shh in their experiments, the exact mechanism
driving Shh expression during ischaemia remains unknown. In
this study, we set out to examine whether hypoxia per se could
induce Hh up-regulation and to elucidate the mechanism behind
this response.
The response to hypoxic conditions is usually mediated through
the hypoxia-inducible factors (HIFs, reviewed in [15]). Under
normal oxygen conditions, the HIF-1 transcription factor is
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constitutively synthesized, but also subject to degradation
thereby keeping HIF-1 protein levels low. Under low oxygen con-
ditions however, the degradation is impaired and HIF-1 levels
rise. After binding to the constitutively present HIF-1 subunit,
the HIF-1 complex binds to consensus sequences present in the
promoter region of hypoxia responsive genes to initiate their tran-
scription. HIF target genes are generally involved in processes like
angiogenesis and cell survival, and as previously mentioned, pos-
sibly Shh as well [11, 14]. In this study, we elucidate the mecha-
nism by which one of the hallmark features of ischaemia, hypoxia,
induces an Hh response and shows the requirement for HIF-1 in
this Hh response by pharmacological and genetic methods.
Methods
Animals and exposure of mice to hypoxia
C57BL/6 wild-type mice were purchased from Charles River (Zeist, The
Netherlands). All mice were housed and fed according to routine proce-
dures and were used at 8–10 weeks of age. The experiments were
approved by the Institutional Animal Care and Use Committee of the
Academic Medical Center, Amsterdam, The Netherlands. Mice were
exposed to normobaric hypoxia using a custom-made hypoxia-chamber
containing an oxygen sensor (Marin Assist, Hazerswoude, The
Netherlands). Mice were placed in the hypoxia chamber and the oxygen
level was lowered to 8% within 1 hr. After 16 hrs of 8% O2, animals were
killed by bleeding from the vena cava inferior after being anaesthetized (by
intraperitoneal injection of FFM ((1:1:2 hypnorm (Janssen Pharmaceutica,
Beerse, Belgium), dormicum (Roche, Mijdrecht, The Netherlands), sterile
water for injection (Braun Melsungen AG, Melsungen, Germany); 0.1 ml
per 10 grams body weight). Immediately before the mice were killed, body
temperature (intrarectal) and weight were measured, pO2, pCO2, HCO3,
haemoglobin and haematocrit levels of mice exposed to 8% O2 were
analysed. Blood was sampled by heart puncture via a lateral approach and
analysed using an ABL 505 blood gas analyser and an OSM3 oxymeter
(Radiometer, Copenhagen, Denmark).
Materials
The 5E1 Shh-blocking antibody was from the Developmental Hybridoma
Bank (Iowa City, IA, USA). Echinomycin was from Alexis Biochemicals
(Lausen, Switzerland). Dimethyloxalylglycine (DMOG) and 2-methoxyestra-
diol (2-ME2) were purchased from Sigma (St. Louis, MO, USA).
Cell culture and exposure of cells to hypoxia
C3H/10T1/2 mouse mesenchymal fibroblasts (from American Type Culture
Collection CCL-226, Manassas, VA, USA) were grown in DMEM (Cambrex,
East Rutherford, NJ, USA) containing 10% foetal calf serum (FCS;
Cambrex). The Shh-LIGHT II mouse fibroblast cell line (ATCC number 
CRL-2795) was maintained in DMEM with 10% FCS, 0.4 mg/ml G418 and
0.16 mg/ml Zeocin. Hif1/ Hras TAg or Hif1/ Hras TAg mouse
embryonic fibroblasts were kindly provided by Dr. Camenisch and grown as
the C3H/10T1/2 cells. H9c2 rat cardiomyoblasts cells [19], ATCC number
© 2008 The Authors
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Fig. 1 Hypoxic mice show a systemic Hedgehog pathway response. (A) Schematic representation of the Hh pathway, showing that Ptch1 inhibits Smo-
dependent signal transduction. Alleviating Ptch1-dependent Smo inhibition by addition of Shh results in pathway activation and expression of Ptch1,
thus creating a negative feedback mechanism. (B) After 1, 4 or 24 hrs of 8% O2, mice were killed (n  2 mice per time point, except for t  0 and 
1 hr for lung and brain). Animals maintained under normal oxygen conditions were used as normoxic controls. Organs (brain, liver, lung and spleen)
were homogenized in lysis buffer and subjected to Western blot analysis using antibodies against Shh. Signals were quantified, corrected for Coomassie
signal and expressed as the percentage increase over the signal for mice from normoxic conditions (expressed as t  0; mean/S.E.M.). 
(C) Quantification of Western blots as for B, but using antibodies against Ptch1.
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CRL1446, were grown in DMEM with 10% FCS. All media were supple-
mented with L-glutamine. Cells were exposed to normobaric hypoxia using
a custom-made hypoxia-chamber and premixed gas containing 1% O2, 5%
CO2 and 94% N2 in a normal cell culture incubator. After incubation, cells
were quickly lysed for Western blot analysis or luciferase assays.
Western blotting
Cells were lysed in Laemmli buffer and brought onto SDS-PAGE gels. After
electrophoresis, protein was transferred onto Immobilon-PVDF mem-
branes (Millipore, Billerica, MA, USA). Membranes were blocked in 3%
Protifar (Nutricia, Zuetermeer, The Netherlands) in Tris-buffered
saline/0.1% Tween-20 (TBST) for 1 hr. Goat polyclonal -Ptch1 G-19
(Santa Cruz Biotechnology, Santa Cruz, CA, USA), 5E1 -Shh
(Developmental Studies Hybridoma Bank, Iowa City, IA, USA), -Shh (Cell
Signaling, Danvers, MA, USA) or -HIF-1 (Novus Biologicals, Littleton,
CO, USA) antibodies were diluted 1:500 (1:1000 for -actin) in 1% BSA
(Sigma-Aldrich) in TBST and membranes were incubated overnight. After
1-hr incubation in 1:1000 -goat or -rabbit HRP-conjugated secondary
antibody (DakoCytomation, Glostrup, Denmark), blots were imaged using
LumiLight Plus ECL (Roche, Basel, Switzerland) on a LAS 3000 Imager
(Fuji Photo Film, Tokyo, Japan). Densitometry was performed using the
histogram function in Adobe Photoshop 7.0 (mean intensity determined in
selection of constant area; Adobe Systems, San Jose, CA, USA).
Luciferase assays
Cells were transfected using Effectene (Qiagen, Hilden, Germany) accord-
ing to the manufacturer’s protocol in 12-well plates (Greiner Bio-One,
Kremsm¸nster, Austria) using 0.5 g DNA/well. Transfection efficiency for
H9c2s was 85% and 70% for the HIF1- knockout and wild-type MEFs.
After transfection and subsequent treatment, cells were lysed with passive
lysis buffer as provided by Promega and luciferase activity was assayed
according to the Promega Dual-Glo Luciferase Assay System protocol on
a Lumat Berthold LB 9501 Luminometer. Firefly luciferase values were cor-
rected for co-transfected Cytomegalovirus (CMV)-driven Renilla luciferase
standard to correct for transfection efficiency or dilution effects. Values
were expressed as percentage difference to control conditions.
Transfections
Transfections of pre-designed siRNA (control and Silencer HIF-1 siRNA;
ID#158954), obtained from Ambion Inc. (Austin, TX, USA), were per-
formed using RNAiFect (Qiagen) according to the manufacturer’s protocol
and as described previously [29]. Cells were incubated with transfection
complexes for 16 hrs, after which fresh medium was added for another 
6 hrs preceding further experimentation.
Cell viability assay
Cells were seeded in 96-well plates and treated with actinomycin D for 
6 hrs, during the last 2 hrs, 5 mg/ml 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium-bromide (MTT) was added and subsequently cells
were lysed in isopropanol and absorbance was read at 560 nm.
Quantitative RT-PCR
After hypoxia, H9c2 cells were lysed in Trizol (Invitrogen, Carlsbad, CA,
USA) and RNA was isolated according to manufacturer’s protocol. After
cDNA synthesis, LightCycler 480 System (Roche Applied Science,
Penzberg, Germany) quantitative PCR was performed with the primers
described in [14].
Statistics
Statistical analyses were conducted using GraphPad Prism version 4.00,
GraphPad software (San Diego, CA, USA). Data are expressed as means 
S.E.M. Comparisons between two conditions were analysed using two-
tailed unpaired t-tests. *, P 	 0.05; **, P 	 0.01; ***, P 	 0.005.
Results
Hypoxia induces a widespread 
Shh response in mice
To study the possible involvement of the Hh pathway in hypoxia,
mice were subjected to decreasing concentrations of oxygen. In
contrast to previous observations [16–18], the threshold of non-
lethal hypoxia was 8% O2 in our hands. The previously reported
level of 5 or 6% O2, which was claimed not to interfere with nor-
mal mouse behaviour, caused immediate death in our animals. At
the observed threshold of 8% O2, the mice became severely
hypothermic within 1 hr. Furthermore, the hypoxic mice showed
signs of dyspnea and did not eat, drink (resulting in reversible
weight loss of 14.43%  0.17 [mean  S.E.M.] after 24 hrs of
hypoxia) or move about normally. Within minutes after re-expo-
sure to ambient oxygen levels, body temperature and behaviour
normalized (data not shown). Confirmation that lowering ambient
oxygen levels to 8% reduces systemic oxygen levels was obtained
from blood gas measurements, arterial pO2 decreased 2.6-fold
from 90 mmHg to 35 mmHg, as a consequence of lowering ambi-
ent O2 levels from 21 to 8%. Venous oxygen levels were 12 mmHg
during hypoxia. In addition, pCO2 and HCO3 values were severely
reduced, suggesting a metabolic acidosis. Together, these data
indicate that the treated mice suffer from quite a severe state of
systemic hypoxia.
To evaluate the activation of the Hh pathway in hypoxic tissue,
we performed Western blot analysis for Shh on whole organ
homogenates from mice exposed to hypoxia for different time
periods. Figure 1B shows increased expression of Shh in spleen,
liver, brain and to a lesser extent in lung following hypoxia. This is
unexpected, as the expression of Shh in the adult organism is
anticipated to be rather limited. However, the observed Shh
response to hypoxia is reminiscent of the up-regulation seen in
ischaemia experiments and might provide a mechanistic explana-
tion for these previous findings.
© 2008 The Authors
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Quantification of Western blot analysis for Ptch1 (Fig. 1C)
shows Ptch1 up-regulation in the analysed organs, and although
liver does not show increased Ptch1 expression, Ptch1 is induced
in lung, spleen and brain. Thus, these organs not only generate
Shh in response to hypoxia, but also respond to it by activation of
the Hh pathway, leading to Ptch1 expression.
Normobaric hypoxia induces a Shh response in an
in vitro model for hypoxic cardiac muscle
The abovementioned data do not explain the exact mechanism by
which Shh expression is triggered by hypoxia, and to be better
able to assess the mechanism behind this Hh response, we
employed an in vitro model system to study Hh pathway activa-
tion. Rat cardiomyoblast cells (H9c2 [19]) were subjected to low
oxygen levels (1% normobaric) in an airtight thermostated cham-
ber and rapidly lysed to avoid any reperfusion effects.
After hypoxic stimulation, cells were lysed and immunoblotted.
As expected, HIF-1 levels rose quickly after exposure to low oxy-
gen levels (Fig. 2A, upper panel). Within 1 hr, maximal levels were
reached. Together with the accumulation of HIF-1, an increase in
mature Shh protein levels was observed (lower panel), peaking
about 1 hr later than HIF-1. In response to the expressed Shh,
Ptch1 levels were also elevated. After 6 hrs of hypoxia, levels of the
analysed proteins had normalized. Densitometric quantification
and statistical justification of Western blots as shown in  
Fig. 2A is shown in Fig. 2B. The kinetics of these results predict that
hypoxia leads to rapid HIF-1 accumulation, which initiates Shh
transcription and translation, leading to pathway activation, and as
a negative feedback, Ptch1 expression. To determine if the rather
rapid up-regulation of Shh depends on de novo protein synthesis
rather than enhanced protein processing, we analysed the level of
Shh transcripts in H9c2 cells following hypoxia. Quantitative real-
time RT-PCR revealed a robust transcription of Shh mRNA within
an hour of hypoxia that rapidly declined in time (Fig. 2C). This
suggests that the observed Shh protein up-regulation observed in 
Fig. 2B is indeed caused by enhanced protein expression.
To formally confirm activation of the Hh pathway transcription
factors in the cardiomyoblasts, these cells were transfected with a
reporter construct that is sensitive to activation of these transcrip-
tion factors, the Gli proteins. In analogy to the observed Ptch1
expression (also indicative of pathway activation), we could
observe induction of reporter activity after 2 hrs of 1% O2, thus
confirming activation of the Hh pathway transcription factors in
response to hypoxia (Fig. 2D). Stimulation of these cells with 
300 ng/ml recombinant Shh activated the Hh pathway to a similar
magnitude as observed with hypoxia. This not only confirms the
Hh-responsiveness of the H9c2 cells, but also provides a clue as to
the amount of Shh produced by the cardiomyoblasts. Interestingly,
we could not observe any Shh in the culture medium using either
Western blot analysis on concentrated medium or ELISA (detection
limits 20 pg/lane and 16 pg/ml respectively), indicative of the
hydrophobic nature of the Hh [20]. This hydrophobicity means that
most newly synthesized and secreted Shh will immediately be
bound to the cell surface, and will never appear in the medium.
© 2008 The Authors
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Fig. 2 Normobaric hypoxia induces a
Hedgehog pathway response in car-
diomyoblasts. (A) H9c2 rat cardiomy-
oblasts were grown to full confluence and
exposed to 1% O2 for the times indicated.
After hypoxia, cells were rapidly lysed and
analysed by Western blot using antibod-
ies against HIF-1, Shh, Ptch1 and 
-actin (loading control). (B) Western
blots as described for A were quantified
as for Fig. 1C. Mean/S.E.M. is shown
of three independent experiments. 
(C) Cardiomyoblasts were exposed to 
1% O2 as for A, and Shh mRNA levels
were assessed by quantitative real-time
RT-PCR. Values were corrected for
GAPDH mRNA levels and expressed as
percentage increase relative to t  0. 
(D) Cardiomyoblasts were transfected
with a Gli-reporter construct and exposed
to 1% O2 or stimulated with 300 ng/ml
Shh for times indicated. After lysis,
luciferase activity was assayed and values
were expressed as percentage increase
relative to t  0. Mean/S.E.M. is
shown, n
 3.
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Using Western blot analysis of H9c2 lysates together with a con-
centration range of commercially available N-terminal Shh, the
intracellular concentration of Shh in the cells after 2 hrs of hypoxia
was estimated to be about 10 pg/1  105 cells.
Normobaric hypoxia induces a 
Shh response in fibroblasts
To be able to use embryonic fibroblasts from mice knockout for
relevant genes, we first needed to confirm that the Hh pathway is
also activated in fibroblasts in response to hypoxia as observed in
the myocardioblasts. The Hh pathway activity in response to
hypoxia was assessed in a murine fibroblast cell line routinely
used for Hh research (NIH-3T3 fibroblasts) stably transfected with
the abovementioned Gli-reporter construct (Shh-LIGHT II [21]).
As shown in Fig. 3A, the fibroblasts respond to hypoxia by activat-
ing the Hh pathway, suggesting that these fibroblasts are a good
model for studying hypoxia-induced Hh responses.
To confirm that Shh expression and secretion is mediating the
Hh pathway response to hypoxia, Hh pathway activation to hypoxia
was determined in the abovementioned Shh-LIGHT II cells pre-
treated with 1 g/ml 5E1 Shh-blocking antibody [22]. The 5E1
antibody binds to the epitope on Shh that is also required for bind-
ing to its receptor Ptch1, and thereby 5E1 inactivates Shh released
into the medium. This treatment was successful in abrogating the
pathway response to hypoxia as shown in Fig. 3B, suggesting that
indeed Shh secretion in response to hypoxia is responsible for
increasing Hh pathway activity. Treatment with an isotype control
antibody did not affect the Hh pathway response to hypoxia.
As mentioned previously, Shh levels were already increased after
60 min. of hypoxia (Fig. 2), which might seem a short time for de
novo protein expression and indeed, the RT-PCR analysis as pre-
sented in Fig. 2C suggests de novo expression to be responsible. We
sought, however, to formally confirm that transcription and transla-
tion are indeed required for Shh levels to rise, by using transcription
and translation blockers on fibroblasts subjected to hypoxia and
determined Shh levels as for Fig. 2A and B. Pre-treatment with 
5 g/ml actinomycin D (transcription inhibitor) or 1 g/ml cyclohex-
imide (translation inhibitor) completely abrogated the expression of
Shh in response to hypoxia (Fig. 3C), confirming that de novo tran-
scription and translation are responsible for the observed Shh pro-
duction and subsequent pathway activation. It is important to note
that in our hands, the used concentration of actinomycin D only
caused a 12% decrease in cell viability after 6 hrs (as determined by
MTT reduction), indicating that toxicity is not likely to be responsible
for the observed abrogation of the Shh response.
HIF-1 mediates the Shh response to hypoxia
Classically, cells sense hypoxic conditions through HIF-1.
HIF-1 accumulates in response to hypoxia and mediates the
transcription of various target genes. An in silico analysis of the
mouse Shh promoter region revealed HIF-1 consensus
sequences (5 tacgtgct 3) at positions 61 to 53 (tacccgct)
© 2008 The Authors
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Fig. 3 Normobaric hypoxia induces a
Hedgehog pathway response in fibrob-
lasts. (A) Shh LIGHT II cells were grown
to full confluence and exposed to 1% 
O2 for times indicated. After lysis,
luciferase activity was assayed and
expressed as described for Fig. 2C.
Mean/S.E.M. is shown, n  6. (B)
Shh LIGHT II cells were preincubated
for 20 min. with 1 g/ml 5E1 Shh-
blocking antibody, IgG control, or no
antibody and exposed to 1% O2 for 
120 min. Antibodies were present in the
medium throughout the entire experi-
ment. After lysis, luciferase activity was
assayed and expressed as described for
Fig. 2C. (C) C3H/10T1/2 cells were pre-
tretated for 20 min. with actinomycin
and cycloheximide at the concentrations
indicated and subsequently subjected to
1% O2 for 120 min. Cells were lysed and
analysed by Western blot using antibod-
ies against Shh, and -actin and densit-
ometry was performed as for Fig. 1B.
Mean/S.E.M. is shown, n  3.
2058
and 1058 to 1050 (tacctgcc) with a 75% match. To test if 
HIF-1 accumulation is required for the Shh response to hypoxia,
we pre-treated Shh-LIGHT II cells with a panel of inhibitors known
to inhibit HIF-1 accumulation, including 2-ME2 [23]. 2-ME2 is a
pharmacological inhibitor that depolymerizes microtubules and
thereby blocks HIF-1 nuclear accumulation in response to
hypoxia [24] and thus paralyses the protein in acting as a tran-
scriptional activator. As can be seen in Fig. 4A, pre-treatment of
cells with 30 M 2-ME2 was able to abrogate Hh pathway activa-
tion following hypoxia. Although this inhibitor is widely used as an
inhibitor of HIF-1, it is also known to interfere with other
processes dependent on microtubule dynamics [24], and we
therefore used another inhibitor known to affect HIF-1 activity in
a different way. By using echinomycin, an inhibitor of HIF-1 bind-
ing to DNA, we were able to abrogate the activation of the Hh path-
way response to hypoxia as well [25]. As both these inhibitors
abrogated Hh pathway activity at least some specificity for HIF-1
inhibition could be argued.
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Fig. 4 HIF-1 mediates the Shh response to hypoxia in vitro. (A) Shh LIGHT II cells were preincubated for 20 min. with the indicated inhibitors and
exposed to 1% O2 for 120 min. After lysis, luciferase activity was assayed and expressed as described for Fig. 2D. DMOG stimulation was performed
under normoxic conditions. (B) Hif1a/ Hras TAg or Hif1a/ Hras TAg mouse embryonic fibroblasts were subjected to hypoxia for the times indicated,
lysed and analysed by Western blot using antibodies against Shh and -actin. (C) Hif1a/ Hras TAg or Hif1a/ Hras TAg mouse embryonic fibroblasts
were transfected with Gli-reporter construct and subjected to 1% O2 for 120 min. and analysed as described for Fig. 2D. (D) Shh LIGHT II cells were trans-
fected with siRNA for HIF-1 or scrambled control and subjected to 120 min. 1% O2, lysed and analysed as described for Fig. 2D. (E) Fibroblasts were
transfected with siRNA for HIF-1 or scrambled control for 24 hrs, subjected to hypoxia for 2 hrs, lysed and analysed by Western blot using antibodies
against HIF-1 and -actin (left panel). Hif1a/ Hras TAg or Hif1a/ Hras TAg mouse embryonic fibroblasts were analysed by Western blot as for left
panel (middle panel). C3H/10T1/2 cells were pretretated for 20 min. with 2-ME2 at the concentration indicated, subjected to 1% O2 for 120 min. and
analysed as for the other two panels (right panel). Dotted line indicates that image consists of two pasted blots of equal exposure settings.
J. Cell. Mol. Med. Vol 13, No 8B, 2009
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By stabilizing HIF-1 under normoxic conditions using the pro-
line hydroxylase inhibitor dimethyloxalylglycine (DMOG [26]), we
could observe Hh pathway activation, further confirming the
observed induction of Hh pathway activation under hypoxic condi-
tions to be dependent on HIF-1 (Fig. 4A).
A more conclusive model to study the requirement for a spe-
cific protein is provided by cells from mice knockout for the gene
encoding that protein. To confirm the necessity of HIF-1 in
hypoxia-induced expression of Shh, we subjected fibroblasts from
mice knockout or wild-type for HIF-1 (Hif1a/ Hras TAg or
Hif1a/ Hras TAg mouse embryonic fibroblasts [27]) to hypoxia
and determined Shh protein levels. As shown in Fig. 4B, Shh lev-
els were raised by low oxygen conditions in fibroblasts from wild-
type mice, whereas fibroblasts from HIF-1 knockout mice were
incapable of this response. This confirms that indeed, HIF-1 is
required for Shh expression in response to hypoxia.
To assess the requirement for HIF-1 in the activation of the
Hh pathway transcription factors by hypoxia, we employed Gli-
reporter transfection of the abovementioned fibroblasts from mice
knockout or wild-type for HIF-1 (Fig. 4C). In the absence of HIF-1,
no activation of the Hh pathway transcription factors could be
observed, providing definitive evidence that HIF-1 is essential in
mediating the Hh response to hypoxia. The requirement for HIF-1
was confirmed with siRNA knockdown of HIF-1 in Shh-LIGHT II
cells (Fig. 4D). Following siRNA knockdown of HIF-1, no induc-
tion of Hh pathway activation by hypoxia could be observed.
Figure 4E (left panel) shows the reduction in HIF-1 protein
level after siRNA transfection and subsequent hypoxia (the
hypoxia was necessary to induce HIF-1 to measurable levels).
Although the reduction in protein is definitely not complete, it is
enough to abrogate the Hh response as shown by the data from
Fig. 4D. Quantification of several silencing experiments is shown.
HIF-1 protein levels in the Hif1/ Hras TAg or Hif1/ Hras
Tag MEFs are shown in the middle panel, showing complete
absence of HIF-1a as expected in the knockout cells. Finally, the
effect of 2-ME2 on HIF-1 accumulation under hypoxic conditions
was confirmed in the rightmost panel. In conclusion, the pre-
sented data show that cells are able to respond to an oxygen-poor
environment by expression of Shh, mediated by HIF-1.
Discussion
In this study, we set out to investigate whether one of the most
prominent features of ischaemia, i.e. hypoxia, was able to induce
an Hh response both in vivo and in vitro. By exposing mice to low
oxygen levels, we were able to show a widespread Hh response.
Mechanistic studies in cardiomyoblasts and fibroblasts mimicked
the effects observed in vivo, and showed that HIF-1 accumula-
tion was required for the Hh response. These findings show that
of the plethora of disturbed processes in ischaemic tissue,
hypoxia per se is able to induce an Hh response. Based on these
data, we propose the following model for Hh action in hypoxic tis-
sue; an occluded vessel restricts blood flow to tissue, which sub-
sequently becomes hypoxic. HIF-1 levels rise due to these
hypoxic conditions leading to de novo expression of Shh subse-
quently activating its pathway. It is tempting to speculate that as a
consequence, transcriptional targets of Shh, like among others,
vascular endothelial growth factor (VEGF) and the angiopoietins
(Ang 1/2) are expressed, thereby leading to tissue vascularization
and the reduction of tissue damage. However, this latter notion
needs to be confirmed in future experiments.
The proposed model would not only explain the up-regulation
of Shh as seen in ischaemia models, but might also have intrigu-
ing implications for other conditions in which individuals are
exposed to low oxygen levels, for instance flight or high altitude
(sometimes leading to significant arterial hypoxia without symp-
toms), or situations such as COPD or asphyxia. An interesting pre-
liminary observation in this regard comes from pilot experiments
involving non-smoking volunteers. After challenging the volun-
teers with tobacco smoke, isolated neutrophils were found to have
almost two-fold higher levels of Ptch1 mRNA within 6 hrs after
first inhalation. It should be noted however that tobacco smoke
does not only induce hypoxia, but affects many other physiologi-
cal processes, making the data from these experiments inconclu-
sive and further studies into this phenomenon are planned.
Some issues should be kept in mind while interpreting our data.
The murine experiments depicted in Fig. 1 clearly indicate that sys-
temic hypoxia leads to Shh expression but they also indicate that
some discrepancy between Shh levels and the subsequent Hh path-
way activity in a given organ exists. Especially the fact that Shh pro-
tein levels are easily detected in liver of mice subjected to hypoxia
whereas no Hh pathway activity is detected in these livers is puzzling.
One could however argue that the amount of Shh produced is not
sufficient to block all Ptch1 receptors. Alternatively, the majority of
hepatocytes might not have a functional Hh pathway and conse-
quently Shh expression does not lead to pathway activation (see also
the data on HepG2 cells in [28]). Whatever the explanation however,
it does not conflict with the main message of our manuscript.
Another matter that should be regarded while interpreting our
data is the speed with which we kill the mice after taking them out
of the hypoxic chamber. Although this was performed as quickly
as possible, it was done in atmospheric oxygen levels, making
short-term reperfusion not a completely unlikely contributor to
our in vivo models.
In summary, we sought to determine whether hypoxia triggers
the Hh pathway, and how. Our data confirm that hypoxia indeed
leads to HIF-1-dependent Shh expression and consequent Hh
pathway activity. We suggest that this activation by hypoxia per se
might explain the observed Shh expression in the ischaemia mod-
els as described by others.
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